PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Editorial

Volume 5 Issue 4

Editorial: Artificial Intelligence in Diabetic Retinopathy

Swarna Biseria Gupta*

March 25, 2025

Abstract

Not only is the global prevalence of Diabetes Mellitus (DM) and Diabetic Retinopathy (DR) expected to increase, but concomitantly the global prevalence of vision-threatening DR (VTDR), which includes diabetic macular edema, severe non-proliferative (NPDR) and proliferative disease (PDR), is also projected to increase. The international number of patients with VTDR is estimated to increase by 57% from 28.5 million in 2020 to 44.8 million in 2045 [1]. Screening to detect early sight-threatening lesions of DR for timely monitoring and treatment is an important strategy to reduce the burden of vision loss due to DR.

References

  1. Luke., et al. “Artificial Intelligence and Ophthalmic Clinical Registries”. American Journal of Ophthalmology 268 (2024): 263-274.
  2. Roglic Gojka. “WHO Global report on diabetes: A summary”. International Journal of Noncommunicable Diseases 1.1 (2016): 3-8.
  3. Taylor CR., et al. “Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: the Vine Hill study”. Diabetes Care 30.3 (2007): 574-8.
  4. Sheng Bin., et al. “An overview of artificial intelligence in diabetic retinopathy and other ocular diseases”. Frontiers in Public Health 10 (2022) 971943.
  5. Yao J., et al. “Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema”. Eye Vis (Lond) 11.1 (2024): 23.
  6. Al-Sari N., et al. “Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes”. EBioMedicine 80 (2022): 104032.
  7. Cao J., et al. “Prediction of response to anti-vascular endothelial growth factor treatment in diabetic macular edema using an optical coherence tomography-based machine learning method”. Acta Ophthalmol 99.1 (2021): e19-e27.
  8. Moosavi Azam., et al. “Imaging Features of Vessels and Leakage Patterns Predict Extended Interval Aflibercept Dosing Using Ultra- Widefield Angiography in Retinal Vascular Disease: Findings from the PERMEATE Study”. IEEE Transactions on Biomedical Engineering (2020): 1-1.
  9. Padhy Srikanta Kumar., et al. “Artificial intelligence in diabetic retinopathy: A natural step to the future”. Indian Journal of Ophthalmology 67.7 (2019): 1004-1009.
  10. Lim JI., et al. “Artificial Intelligence Detection of Diabetic Retinopathy: Subgroup Comparison of the EyeArt System with Ophthalmologists' Dilated Examinations”. Ophthalmol Sci 3.1 (2022): 100228.